New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Laurel Damashek

Laurel Damashek is the founding Executive Director of the International Society of Glomerular Disease. She brings a unique perspective to the role, being a glomerular disease patient herself. She was diagnosed at age 12 with FSGS and received a transplant from a close friend in 2016. During her kidney disease journey, she became a volunteer and eventually a board member at NephCure. She is deeply dedicated to improving the clinical ecosystem for everyone affected by rare kidney disease. Before dedicating her full-time career to kidney health, Laurel spent 15 years as a project and product manager in various domains of publishing, medical devices, translation and localization, and leading a team developing Anthem Award and Brandon Hall Award-winning ethics and compliance e-learning.

She holds a master’s degree from the University of Toronto, where she was a Junior Fellow at Massey College, and a bachelor’s degree from Smith College. She is proficient in Spanish, German, and Chinese, with reading knowledge of a few other languages. Laurel is based in Massachusetts. In her free time, she enjoys the arts, the outdoors, and playing the cello.

Massachusetts

Related News

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.